Preview

Izmeritel`naya Tekhnika

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Reference materials of composition biologically active substances

https://doi.org/10.32446/0368-1025it.2020-4-66-71

Abstract

To ensure the uniformity of measurements and ensure metrological traceability of the measurement results in the field of ensuring the uniformity of measurements state regulation, including in the areas of healthcare and pharmaceuticals, reference materials of the composition, properties and structure of substances are needed. Currently, the Federal Information Fund of the Russian Federation has approximately 9000 reference materials, among which only about 30 reference materials are intended for use in pharmaceuticals and medicine. This amount is clearly not enough for full metrological support of these areas. This article describes the main stages and results of research and development of starting pharmaceutical substances reference materials of amphotericin B, natamycin, olivomycin A. The main substances of the created reference materials are identified. Mass fractions of related compounds, residual organic solvents and inorganic impurities (iron cations and heavy metals) were determined. The results of the work were used to confirm the reference materials types of the starting pharmaceutical substances amphotericin B, natamycin, olivomycin A.

About the Authors

E. V. Kuliabina
Russian research institute of metrological service
Russian Federation

Elena V. Kuliabina

Moscow



A. N. Tevyashova
FSBI Gause Institute of New Antibiotics
Russian Federation

Anna N. Tevyashova

Moscow



S. E. Solov’eva
FSBI Gause Institute of New Antibiotics
Russian Federation

Svetlana E. Solov’eva

Moscow



O. N. Melkova
Russian research institute of metrological service
Russian Federation

Olga N. Melkova

Moscow



E A. Guskova
Russian research institute of metrological service
Russian Federation

Ekaterina A. Guskova

Moscow 



References

1. . International vocabulary of metrology – Basic and general concepts and associated terms (VIM) 3rd edition, available at: https://www.bipm.org/utils/common/documents/jcgm/JCGM_200_2012.pdf (accessed: 10/01/2020).

2. Yashpal S. Chhonker, Yarra Durga Prasad, Hardik Chandasana, Akhilesh Vishvkarma, Kalyan Mitra, Praveen K. Shukla, Rabi S. Bhatta, International Journal of Biological Macromolecules, 2015, vol. 72, pp. 1451–1458. DOI:10.1016/j.ijbiomac.2014.10.014

3. Lyes Mehenni, Malika Lahiani-Skiba, Guy Ladam, François Hallouard, and Mohamed Skiba, Pharmaceutics, November 2018, vol. 10 (4), p. 235. DOI:10.3390/pharmaceutics10040235

4. Tevyashova A. N., Pharmaceutical Chemistry Journal, 2016, vol. 50, no. 7, pp. 3–5. DOI:10.30906/0023-1134-2016-50-7-3-8

5. Houssam M. Atta, Sh. M. Selim, and Mona S. Zayed, Journal of American Science, 2012, vol. 8 (2), pp. 469–475, available at: http://www.americanscience.org(accessed:10.01.2020).

6. Sowinski P., Pawlak J., Borowski E., Magnetic Resonance In Chemistry, 1992, vol. 30, pp. 275–279. DOI:10.1002/mrc.1260300402

7. Brown J. M., Sidebottom P. J., Tetrahedron, 1981, vol. 37, pp. 1421–1428.

8. Volpon L., Lancelin J.-M., European Journal of Biochemistry, 2002, vol. 269, pp. 4533–4541. DOI: 10.1046/j.1432-1033.2002.03147.x

9. Yoshimura Y., Koenuma M., Matsumoto K., Tori K., Terui Y., Journal Antibiot (Tokyo), 1988, vol. 41, pp. 53–67. DOI: 10.7164/antibiotics.41.53

10. Grundt P., Findeisen T., Miethke E., Jäger P., AhmadNejad, and Neumaier M., Journal of Clinical Microbiology, February 2012, vol. 50 (5), p. 1727-9. DOI:10.1128/JCM.00047-12

11. Vishal Diwan, Ashok J. Tamhankar, Rakesh K. Khandal, Shanta Sen, Manjeet Aggarwal, Yogyata Marothi, Rama V. Iyer, Karin Sundblad-Tonderski, and Cecilia Stålsby-Lundborg, BMC Public Health, July 2010, vol. 10 (1), p. 414. DOI:10.1186/1471-2458-10-414

12. Prakash Srinivasan, Ajit K. Sarmah, Merilyn ManleyHarris & Alistair L. Wilkins, Journal of Environmental Science and Health, Part A: Toxic/Hazardous Substances and Environmental Engineering, 2012, vol. 47 (13), pp. 2120–2132. DOI:10.1080/10934529.2012.696005

13. Zampia Tzouganaki, Michael Koupparis, Mediterranean Journal of Chemistry, 2017, vol. 6 (4), pp. 133–141. DOI:10.13171/mjc64/01706211420-tzouganaki

14. Patil P. N., Shery Jacob, International Journal of Pharmaceutical Sciences and Research, 2012, vol. 3 (1). DOI:10.15373/22501991/APR2014/98

15. Yuexi Yang, Chen Huan, Xianrui Liang, Sheng Fang, Jian Wang, and Jie Chen, Molecules, November 2019, vol. 24 (21), p. 3962. DOI:10.3390/molecules24213962

16. Rajamani Lakshminarayanan, Radhakrishnan Sridhar, Xian Jun Loh, Muruganantham Nandhakumar, Veluchamy Amutha Barathi, Madhaiyan Kalaipriya,Jia Lin Kwan, Shou Ping Liu, Roger Wilmer Beuerman, Seeram Ramakrishna, International Journal of Nanomedicine, May 2014, vol. 9 (1), p. 439–458. DOI:10.2147/IJN.S58487


Review

For citations:


Kuliabina E.V., Tevyashova A.N., Solov’eva S.E., Melkova O.N., Guskova E.A. Reference materials of composition biologically active substances. Izmeritel`naya Tekhnika. 2020;(4):66-71. (In Russ.) https://doi.org/10.32446/0368-1025it.2020-4-66-71

Views: 74


ISSN 0368-1025 (Print)
ISSN 2949-5237 (Online)